When combining RTX-IgG2 with the phagocytosis-efficient RTX-IgG1 or RTX-IgG3, it significantly enhances phagocytosis of B-cell lymphoma cells. Here, IGHG3 is linked to B-cell non-Hodgkin lymphoma.